CeGaT
German Precision Medicine Model Project Gets Ready for Kickoff as Commercial Providers Cry Foul
The €700 million project will pilot diagnostic genomic testing for cancer and rare diseases for at least five years, but private labs cannot participate.
Response to Combined Immunotherapy in Melanoma Associated With TMB, Cell-Free DNA, ctDNA
A prospective study in 35 advanced melanoma patients found that response to combined Yervoy and Opdivo was correlated with the three markers.